Dual GIP/GLP-1 receptor agonist with B12. SURMOUNT trial: avg 20.9% body weight loss. Rx required.
Tirzepatide is a dual GIP and GLP-1 receptor agonist for superior metabolic health and weight management. It outperforms single-agonist approaches in clinical trials. Combined with B12 for enhanced metabolic support. Available in multiple strengths with physician-guided dosing.
Every compound in our catalog is selected based on published clinical evidence and dispensed from DEA-compliant US pharmacies. Your physician determines whether this program is appropriate for your health profile during intake review.
Your starting dose, titration schedule, and progression must be determined based on your individual health profile. Selecting your own dose is not safe and is not permitted. Every order is reviewed by a licensed physician before dispensing.
Complete our universal health intake form. It covers your medical history, current medications, goals, and contraindications. Takes approximately 5 minutes.
A licensed physician reviews your intake within 24–48 hours. If your profile is suitable, a prescription is issued and your program is prepared. If not, you'll receive a clear explanation and full refund.
Your program ships from a licensed US pharmacy directly to your door. Discreet packaging, nationwide delivery, tracking provided.
Your physician remains available throughout the program for dosage adjustments, questions, and progression guidance. Support is not limited to the intake — it continues for the full program duration.
* Images are for illustration purposes only; not representative of the actual product received.
All programs require physician review and prescription approval. Compounded preparations are not FDA-approved. Individual results vary. This page does not constitute medical advice — your physician will determine whether this program is appropriate for you during intake review.
